This trial is testing if injecting a dye-labeled particle can help visualize cancerous lymph nodes in head and neck cancer patients. This is to improve upon the current standard of care scans.
1 Primary · 0 Secondary · Reporting Duration: 1 year
Experimental Treatment
86 Total Participants · 1 Treatment Group
Primary Treatment: fluorescent cRGDY-PEG-Cy5.5-C dots · No Placebo Group · Phase 1 & 2
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: